Avoid unnecessary appointments, by keeping patients on track
Prostate cancer is reported as the second most common cancer in men, impacting the life of 1 in every 8 men. After local treatment, prostate-specific antigen (PSA) monitoring is widely recognized as the gold-standard for follow-up. However, nowadays, this follow-up depends on a physical appointment with a physician.
What does Hilly do?
Gathers clinical information;
Automates requests for PSA measurement according to trigger symptoms, previous results, progression and follow-up duration.
Reduce the time spent on repetitive and low-value tasks;
Avoid unnecessary appointments;
Faster detection of red flags signs/symptoms of an imminent decompensation;
Optimize the use of resources, reduce costs and increase capacity.
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2022 Update. https://uroweb.org/guidelines/prostate-cancer